KPRX
NASDAQ · Pharmaceuticals
Kiora Pharmaceuticals Inc
$2.57
-0.02 (-0.77%)
Open$2.59
Previous Close$2.59
Day High$2.60
Day Low$2.52
52W High$3.29
52W Low$1.76
Volume—
Avg Volume31.2K
Market Cap11.21M
P/E Ratio—
EPS$-2.62
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,041.6% upside
Current
$2.57
$2.57
Target
$29.34
$29.34
$16.75
$29.34 avg
$32.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 15.53M | 8.57M | 1.95M |
| Net Income | 3.48M | 1.73M | 336.4K |
| Profit Margin | 22.4% | 21.3% | 17.3% |
| EBITDA | 4.31M | 2.26M | 564.5K |
| Free Cash Flow | — | — | 437.5K |
| Rev Growth | +81.3% | +81.3% | -4.0% |
| Debt/Equity | — | — | 0.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |